Ability of triglyceride‐glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity
Authors:
Open Access
- 22 August 2025
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (5) , 1287-1295
Abstract
Objectives: We aimed to evaluate the best cut‐off of alanine aminotransferase (ALT) to predict the metabolic dysfunction‐associated steatotic liver disease (MASLD) in youths with overweight/obesity (OW/OB) and analyze the performance of the triglyceride‐glucose index (TyG) or its association with anthropometric variables compared to ALT. Methods: This multicenter, cross‐sectional study analyzed data of 2813 youths (1463 boys and 1350 girls) aged 6–17 years recruited in 10 Italian centers for the management of pediatric OB. Exclusion criteria were: body mass index (BMI) Z ‐score >5, diabetes, secondary obesity, triglycerides (TG) ≥ 400 mg/dL. MASLD was defined on the presence of hepatic steatosis at abdominal ultrasound, in combination with at least one cardiometabolic risk factor. The performance of ALT and TyG‐derived indices for MASLD diagnosis was assessed using the receiver operation curve and the area under the curve (AUC) with the 95% confidence intervals were obtained. Results: MASLD was observed in 1278 youths (45.1%). The global AUC of ALT was 0.661 (0.641–0.682), p < 0.0001. Using Youden's index the best cut‐off of ALT was ≥26 IU/L in boys and ≥22 IU/L in girls. The AUCs of TyG‐BMI, TyG‐WC, and TyG‐ALT were 0.678 (0.659–0.698), 0.659 (0.639–0.679), and 0.666 (0.645–0.686), respectively. Using Delong's test none TyG‐derived index showed a better performance than ALT alone. Conclusions: This study demonstrates that the values of ALT ≥ 26 IU/L in boys and ≥22 IU/L in girls can be used for the screening of MASLD in youths with OW/OB, while the combination of TyG‐derived indices is not superior to ALT alone.Keywords
This publication has 37 references indexed in Scilit:
- Pediatric MASLD: current understanding and practical approachEuropean Journal of Pediatrics, 2024
- Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysisWorld Journal of Pediatrics, 2024
- MAFLD as part of systemic metabolic dysregulationHepatology International, 2024
- Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclatureJournal of Pediatric Gastroenterology and Nutrition, 2024
- MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damageJournal of Hepatology, 2023
- Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in childrenClinics and Research in Hepatology and Gastroenterology, 2023
- A natural history study of paediatric non-alcoholic fatty liver disease over 10 yearsJHEP Reports, 2023
- Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescentsJHEP Reports, 2019
- Prevalence of Nonalcoholic Fatty Liver Disease in Children with ObesityThe Journal of Pediatrics, 2019
- The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease, 2016